Development
Cullinan Therapeutics, Inc.
CGEM
$7.88
-$0.20-2.48%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 0.14% | -5.16% | 25.88% | -16.39% | -18.87% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 27.64% | 59.73% | -22.73% | 16.03% | 17.24% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 0.73% | -4.32% | 24.86% | -15.90% | -18.49% |
|
|||||
Total Current Assets | 0.73% | -4.32% | 24.86% | -15.90% | -18.49% |
Net Property, Plant & Equipment | -11.50% | -14.34% | -7.89% | -4.64% | 0.30% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -0.22% |
Total Assets | -2.13% | -5.23% | 1.36% | -8.22% | -9.09% |
|
|||||
Total Accounts Payable | 162.15% | -61.85% | 22.75% | -23.65% | 75.46% |
Total Accrued Expenses | 33.50% | 38.28% | 10.47% | -4.85% | 11.53% |
Short-term Debt | -- | 1.96% | 1.95% | 938.76% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -6.92% | -6.36% | 6.31% | 9.36% | 104.17% |
Total Finance Division Other Current Liabilities | -42.08% | 53.20% | -88.94% | 49.38% | -55.90% |
Total Other Current Liabilities | -42.08% | 53.20% | -88.94% | 49.38% | -55.90% |
Total Current Liabilities | 20.02% | 19.15% | -24.82% | 16.33% | -17.03% |
|
|||||
Total Current Liabilities | 20.02% | 19.15% | -24.82% | 16.33% | -17.03% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | 1.96% | 1.95% | 938.76% | -- |
Capital Leases | -12.10% | -10.53% | -13.75% | -11.70% | -10.07% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 16.98% | 15.53% | -23.62% | 12.47% | -16.14% |
|
|||||
Common Stock & APIC | 1.20% | 1.23% | 7.85% | 1.23% | -4.20% |
Retained Earnings | -13.44% | -28.42% | -30.49% | -121.53% | -128.06% |
Treasury Stock & Other | 87.73% | 35.32% | -30.84% | 52.25% | 33.80% |
Total Common Equity | -3.22% | -6.16% | 2.87% | -9.23% | -8.72% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -3.22% | -6.16% | 2.87% | -9.23% | -8.72% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -3.18% | -6.16% | 2.87% | -9.23% | -8.72% |
|